Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biospecifics Technologies Corp (NASDAQ:BSTC)

52.05
Delayed Data
As of 4:00pm ET
 +1.75 / +3.48%
Today’s Change
35.79
Today|||52-Week Range
58.79
-6.55%
Year-to-Date
No recent news for Biospecifics Technologies Corp.

Today’s Trading

Previous close50.30
Today’s open50.41
Day’s range50.41 - 53.77
Volume22,124
Average volume (3 months)29,455
Market cap$360.8M
Dividend yield--
Data as of 4:00pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+18.18%
Earnings growth (this year)+10.90%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+15.39%
P/E ratio31.9
Price/Sales15.45
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc+0.05+0.90%
AVXLAnavex Life Sciences...-0.13-2.60%
CASCCascadian Therapeuti...0.000.00%
RGNXRegenxbio Inc+0.05+0.27%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$0.39
Annual revenue (last year)$26.3M
Annual profit (last year)$11.4M
Net profit margin43.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Thomas L. Wegman
Corporate headquarters
Lynbrook, New York

Forecasts